Literature DB >> 1442353

[Enhanced production of in vitro tumor necrosis factor-alpha from monocytes in Behçet's disease].

S Nakamura1, M Sugita, S Tanaka, S Ohno.   

Abstract

In vitro tumor necrosis factor-alpha (TNF-alpha) production from peripheral blood monocytes (PBMC) was investigated among 12 patients (male: 7, female: 5) with uveoretinitis of Behçet's disease and 6 age-matched healthy controls. TNF-alpha production of PBMC after the stimulation with lipopolysaccharides (LPS) was significantly enhanced in Behçet's disease patients with active uveoretinitis (21.5 +/- 2.8 U/ml) compared with both controls (5.7 +/- 1.8 U/ml) (p < 0.01) and inactive cases (5.1 +/- 1.4 U/ml) (p < 0.01). In the cases with active uveoretinitis, TNF-alpha production in the period of ocular attack (7.2 +/- 6.2 U/ml) was significantly lower than that of the post-attack period (24.4 +/- 13.9 U/ml) (p < 0.02). These results may indicate that TNF-alpha plays an important role in the immunopathogenesis of uveoretinitis in Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442353

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  4 in total

1.  Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Authors:  Sunao Sugita; Yuko Kawazoe; Ayano Imai; Yukiko Yamada; Shintaro Horie; Manabu Mochizuki
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

2.  Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet's disease: a large-scale, long-term postmarketing surveillance in Japan.

Authors:  Shigeaki Ohno; Itsuro Umebayashi; Miyuki Matsukawa; Takashi Goto; Toshiro Yano
Journal:  Arthritis Res Ther       Date:  2019-01-05       Impact factor: 5.156

3.  Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet's disease.

Authors:  Atsuko Katsuyama; Sentaro Kusuhara; Ryuto Nishisho; Wataru Matsumiya; Atsushi Azumi; Makoto Nakamura
Journal:  Clin Ophthalmol       Date:  2019-03-20

Review 4.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.